{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:19Z","timestamp":1790937139576,"version":"4.1.0"},"reference-count":246,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Malaria remains one of the most prevalent infectious diseases worldwide, primarily affecting some of the most vulnerable populations around the globe. Despite achievements in the treatment of this devastating disease, there is still an urgent need for the discovery of new drugs that tackle infection by Plasmodium parasites. However, de novo drug development is a costly and time-consuming process. An alternative strategy is to evaluate the anti-plasmodial activity of compounds that are already approved for other purposes, an approach known as drug repurposing. Here, we will review efforts to assess the anti-plasmodial activity of existing drugs, with an emphasis on the obligatory and clinically silent liver stage of infection. We will also review the current knowledge on the classes of compounds that might be therapeutically relevant against Plasmodium in the context of other communicable diseases that are prevalent in regions where malaria is endemic. Repositioning existing compounds may constitute a faster solution to the current gap of prophylactic and therapeutic drugs that act on Plasmodium parasites, overall contributing to the global effort of malaria eradication.<\/jats:p>","DOI":"10.3390\/molecules25153409","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T12:15:38Z","timestamp":1596111338000},"page":"3409","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Repurposing Drugs to Fight Hepatic Malaria Parasites"],"prefix":"10.3390","volume":"25","author":[{"given":"Diana","family":"Fontinha","sequence":"first","affiliation":[{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Moules","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1746-6029","authenticated-orcid":false,"given":"Miguel","family":"Prud\u00eancio","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.bmcl.2013.03.067","article-title":"Recent advances in malaria drug discovery","volume":"23","author":"Biamonte","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_2","unstructured":"World Health Organization (2019). World Malaria Report 2019, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","article-title":"Malaria: Progress, perils, and prospects for eradication","volume":"118","author":"Greenwood","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro1529","article-title":"The silent path to thousands of merozoites: The Plasmodium liver stage","volume":"4","author":"Prudencio","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: Biology and Disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1126\/science.291.5501.141","article-title":"Migration of Plasmodium sporozoites through cells before infection","volume":"291","author":"Mota","year":"2001","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.20121130","article-title":"Role of host cell traversal by the malaria sporozoite during liver infection","volume":"210","author":"Tavares","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Graewe, S., Rankin, K.E., Lehmann, C., Deschermeier, C., Hecht, L., Froehlke, U., Stanway, R.R., and Heussler, V. (2011). Hostile takeover by Plasmodium: Reorganization of parasite and host cell membranes during liver stage egress. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002224"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.chom.2017.07.003","article-title":"The Molecular Basis of Erythrocyte Invasion by Malaria Parasites","volume":"22","author":"Cowman","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug Repurposing: Progress, Challenges and Recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"Drug repurposing for antimicrobial discovery","volume":"4","author":"Farha","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pantziarka, P., Pirmohamed, M., and Mirza, N. (2018). New uses for old drugs. BMJ, 361.","DOI":"10.1136\/bmj.k2701"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: The pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"Pink","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of drug repositioning approaches and resources","volume":"14","author":"Xue","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4269\/ajtmh.2011.11-0288","article-title":"Short report: Amebiasis-related mortality among United States residents, 1990\u20132007","volume":"85","author":"Gunther","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the Teatment of Lepra Reactions","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.drudis.2014.05.012","article-title":"An analysis of FDA-approved drugs for infectious disease: HIV\/AIDS drugs","volume":"19","author":"Kinch","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","article-title":"The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-related Complex. A Double-Blind, Placebo-Controlled Trial","volume":"317","author":"Fischl","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"282ra49","DOI":"10.1126\/scitranslmed.3010286","article-title":"Repurposing of the Antihistamine Chlorcyclizine and Related Compounds for Treatment of Hepatitis C Virus Infection","volume":"7","author":"He","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_23","unstructured":"Centers for Disease Control and Prevention (2020, May 22). Choosing a Drug to Prevent Malaria, Available online: https:\/\/www.cdc.gov\/malaria\/travelers\/drugs.html."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","article-title":"Targeting the hypnozoite reservoir of Plasmodium vivax: The hidden obstacle to malaria elimination","volume":"26","author":"Wells","year":"2010","journal-title":"Trends Parasitol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s40265-018-0979-2","article-title":"Tafenoquine: First Global Approval","volume":"78","author":"Frampton","year":"2018","journal-title":"Drugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.124.3220.484.b","article-title":"Enzymatic deficiency in primaquine-sensitive erythrocytes","volume":"124","author":"Alving","year":"1956","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1128\/AAC.01043-07","article-title":"New active drugs against liver stages of Plasmodium predicted by molecular topology","volume":"52","author":"Mahmoudi","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.50.2.639-648.2006","article-title":"Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria","volume":"50","author":"Andrews","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.00169-08","article-title":"Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum","volume":"52","author":"Suwanarusk","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.00085-11","article-title":"Antimalarial effects of human immunodeficiency virus protease inhibitors in rhesus macaques","volume":"55","author":"Li","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1128\/AAC.05130-11","article-title":"In Vitro activity of antiretroviral drugs against Plasmodium falciparum","volume":"55","author":"Nsanzabana","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/AAC.49.7.2983-2985.2005","article-title":"Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors","volume":"49","author":"Parikh","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/AAC.01512-09","article-title":"Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors","volume":"54","author":"Peatey","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1086\/425584","article-title":"Antiretrovirals as antimalarial agents","volume":"190","author":"McCarthy","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jit132","article-title":"HIV treatments have malaria gametocyte killing and transmission blocking activity","volume":"208","author":"Hobbs","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/QAD.0b013e3283621dd4","article-title":"The effect of antiretrovirals on Plasmodium falciparum liver stages","volume":"27","author":"Hobbs","year":"2013","journal-title":"AIDS"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/594369","article-title":"HIV protease inhibitors inhibit the development of preerythrocytic-stage Plasmodium parasites","volume":"199","author":"Hobbs","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fcimb.2017.00329","article-title":"Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds","volume":"7","author":"Machado","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1179\/1973947813Y.0000000158","article-title":"The effect of lopinavir\/ritonavir on the antimalarial activity of artemether or artemether\/lumefantrine in a mouse model of Plasmodium berghei","volume":"27","author":"Abiodun","year":"2015","journal-title":"J. Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/QAD.0b013e328031f41a","article-title":"Antimalarial activity of sera from subjects taking HIV protease inhibitors","volume":"21","author":"Redmond","year":"2007","journal-title":"AIDS"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hobbs, C.V., Dixit, S., Penzak, S.R., Sahu, T., Orr-Gonzalez, S., Lambert, L., Zeleski, K., Chen, J., Neal, J., and Borkowsky, W. (2014). Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in Plasmodium cynomolgi-infected non-human primates. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0115506"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/infdis\/jis602","article-title":"HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit Plasmodium liver stages","volume":"206","author":"Hobbs","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4269\/ajtmh.2012.11-0209","article-title":"Antimalaria action of antiretroviral drugs on Plasmodium berghei in mice","volume":"88","author":"Akinyede","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00034983.1989.11812333","article-title":"Antimalarial activity of demeclocycline against Plasmodium cynomolgi bastianellii in rhesus monkeys","volume":"83","author":"Kumar","year":"1989","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_45","first-page":"32","article-title":"The action of \u2018terramycin\u2019 on the primary exoerythrocytic development of Plasmodium vivax and Plasmodium cynomolgi ceylonensis","volume":"74","author":"Garnham","year":"1971","journal-title":"J. Trop. Med. Hyg."},{"key":"ref_46","first-page":"519","article-title":"Tissue schizontocidal activity of minocycline against a relapsing malaria parasite Plasmodium cynomolgi B","volume":"85","author":"Kumar","year":"1987","journal-title":"Indian J. Med. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/infdis\/jis184","article-title":"Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug","volume":"205","author":"Martin","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/AAC.45.6.1746-1750.2001","article-title":"In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron","volume":"45","author":"Pradines","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0035-9203(73)90279-4","article-title":"The action of minocycline, a tetracycline derivative on drug-resistant P. berghei","volume":"67","author":"Kaddu","year":"1973","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00034983.1974.11686922","article-title":"The chemotherapy of rodent malaria, XIX. The action of a tetracycline derivative, minocycline, on drug-resistant Plasmodium berghei","volume":"68","author":"Kaddu","year":"1974","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cyto.2016.11.001","article-title":"Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection","volume":"90","author":"Apoorv","year":"2017","journal-title":"Cytokine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0014-4894(76)90073-4","article-title":"Plasmodium berghei: Development of resistance to clindamycin and minocycline in mice","volume":"40","author":"Jacobs","year":"1976","journal-title":"Exp. Parasitol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4269\/ajtmh.2012.11-0552","article-title":"Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances","volume":"86","author":"Deye","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/infdis\/168.6.1603","article-title":"Activity of doxycycline against preerythrocytic malaria","volume":"168","author":"Marussig","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1128\/AAC.00394-06","article-title":"Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum","volume":"50","author":"Dahl","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/648594","article-title":"Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers","volume":"201","author":"Briolant","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4269\/ajtmh.2000.62.82","article-title":"Antibiotics for prophylaxis of Plasmodium falciparum infections: In vitro activity of doxycycline against Senegalese isolates","volume":"62","author":"Pradines","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1128\/AAC.38.8.1862","article-title":"Efficacy of azithromycin as a causal prophylactic agent against murine malaria","volume":"38","author":"Andersen","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"40ra49","DOI":"10.1126\/scitranslmed.3001058","article-title":"Natural immunization against malaria: Causal prophylaxis with antibiotics","volume":"2","author":"Friesen","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1074\/jbc.M608615200","article-title":"In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin","volume":"282","author":"Sidhu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.1992.47.378","article-title":"Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro","volume":"47","author":"Gingras","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4269\/ajtmh.1993.49.101","article-title":"Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei","volume":"49","author":"Gingras","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pt.2008.03.007","article-title":"Apicoplast translation, transcription and genome replication: Targets for antimalarial antibiotics","volume":"24","author":"Dahl","year":"2008","journal-title":"Trends Parasitol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.47.8.2636-2639.2003","article-title":"In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp.","volume":"47","author":"Mahmoudi","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/AAC.32.8.1182","article-title":"Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro","volume":"32","author":"Divo","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(99)00051-0","article-title":"In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone","volume":"74","author":"Hamzah","year":"2000","journal-title":"Acta Trop."},{"key":"ref_68","first-page":"67","article-title":"In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum","volume":"30","author":"Tripathi","year":"1993","journal-title":"Indian J. Malariol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molbiopara.2007.01.005","article-title":"The effects of anti-bacterials on the malaria parasite Plasmodium falciparum","volume":"152","author":"Goodman","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/AAC.34.12.2327","article-title":"Activities of pefloxacin and ciprofloxacin against experimental malaria in mice","volume":"34","author":"Salmon","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2307\/3283363","article-title":"Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases anti-malarial activity","volume":"80","author":"Yeo","year":"1994","journal-title":"J. Parasitol."},{"key":"ref_72","first-page":"213","article-title":"Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs","volume":"50","author":"Fink","year":"1974","journal-title":"Bull. World Health Organ."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Hobbs, C.V., Neal, J., Conteh, S., Donnelly, L., Chen, J., Marsh, K., Lambert, L., Orr-Gonzalez, S., Hinderer, J., and Healy, S. (2014). HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100138"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0035-9203(87)90226-4","article-title":"In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination","volume":"81","author":"Petersen","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0035-9203(91)90285-7","article-title":"Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole","volume":"85","author":"Daramola","year":"1991","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0035-9203(70)90039-8","article-title":"Drug Sensitivity of Exo-Erythrocytic Stages in Pyrimethamine-Resistant Plasmodium berghei","volume":"64","author":"Diggens","year":"1970","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0035-9203(51)90007-7","article-title":"Morphological Changes in Plasmodium cynomolgi Following Proguanil, Sulphadiazine, and Mepacrine Therapy","volume":"44","author":"McFadzean","year":"1951","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0035-9203(51)90006-5","article-title":"Morphological Changes in Plasmodium berghei Following Proguanil, Sulphadiazine and Mepacrine Therapy","volume":"44","author":"Thurston","year":"1951","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4269\/ajtmh.1966.15.823","article-title":"The Evaluation of Sulfonamides, Alone or in Combination with Pyrimethamine, in the Treatment of Multi-Resistant Falciparum Malaria","volume":"15","author":"Chin","year":"1966","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Mendes, A.M., Albuquerque, I.S., Machado, M., Pissarra, J., Meireles, P., and Prudencio, M. (2017). Inhibition of Plasmodium Liver Infection by Ivermectin. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.02005-16"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"De Carvalho, L.P., Sandri, T.L., Jose Tenorio de Melo, E., Fendel, R., Kremsner, P.G., Mordmuller, B., and Held, J. (2019). Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro. Antimicrob. Agents Chemother., 63.","DOI":"10.1128\/AAC.00085-19"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1038\/cddis.2013.521","article-title":"Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP","volume":"5","author":"Panchal","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/j.1460-2075.1993.tb05950.x","article-title":"Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes","volume":"12","author":"Muller","year":"1993","journal-title":"EMBO J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"47670","DOI":"10.1074\/jbc.M306603200","article-title":"Suramin and suramin analogues inhibit merozoite surface protein-1 secondary processing and erythrocyte invasion by the malaria parasite Plasmodium falciparum","volume":"278","author":"Fleck","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1096\/fj.04-3371fje","article-title":"Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes","volume":"20","author":"Tanneur","year":"2006","journal-title":"FASEB J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0166-6851(90)90189-S","article-title":"Expression, purification, biochemical characterization and inhibition of recombinant Plasmodium falciparum aldolase","volume":"41","author":"Dobeli","year":"1990","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1570-9639(04)00025-1","article-title":"Biochemical characterization and crystallization of recombinant 3-phosphoglycerate kinase of Plasmodium falciparum","volume":"1699","author":"Pal","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.bmc.2013.04.047","article-title":"Falcipain-2 inhibition by suramin and suramin analogues","volume":"21","author":"Marques","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"19981","DOI":"10.1038\/srep19981","article-title":"Structural and functional attributes of malaria parasite diadenosine tetraphosphate hydrolase","volume":"6","author":"Sharma","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0035-9203(82)90105-5","article-title":"Inhibitory action of alpha-difluoromethylornithine on rodent malaria (Plasmodium berghei)","volume":"76","author":"Gillet","year":"1982","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/00034983.1997.11813117","article-title":"Evaluation of alpha-difluoromethylornithine (DFMO) as a tool to induce protective immunity against Plasmodium berghei malaria","volume":"91","author":"Francois","year":"1997","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-4894(85)80028-X","article-title":"Plasmodium berghei: Inhibitors of ornithine decarboxylase block exoerythrocytic schizogony","volume":"60","author":"Hollingdale","year":"1985","journal-title":"Exp. Parasitol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0035-9203(86)90022-2","article-title":"alpha-Difluoromethylornithine induces protective immunity in mice inoculated with Plasmodium berghei sporozoites","volume":"80","author":"Gillet","year":"1986","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_94","first-page":"301","article-title":"alpha-Difluoromethylornithine inhibits the first part of exoerythrocytic schizogony of Plasmodium berghei in rodents","volume":"66","author":"Lowa","year":"1986","journal-title":"Ann. Soc. Belg. Med. Trop."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-4894(87)90148-2","article-title":"Plasmodium falciparum and Plasmodium berghei: Effects of ornithine decarboxylase inhibitors on erythrocytic schizogony","volume":"64","author":"Bitonti","year":"1987","journal-title":"Exp. Parasitol."},{"key":"ref_96","first-page":"918","article-title":"Antimalarial effect of agmatine on Plasmodium berghei K173 strain","volume":"24","author":"Su","year":"2003","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_97","first-page":"97","article-title":"Effect on parasitic protozoa of alpha-Difluoromethylornithine, an inhibitor of ornithine decarboxylase","volume":"3","author":"McCann","year":"1981","journal-title":"Adv. Polyam. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj2220815","article-title":"Polyamine levels and the activity of their biosynthetic enzymes in human erythrocytes infected with the malarial parasite, Plasmodium falciparum","volume":"222","author":"Assaraf","year":"1984","journal-title":"Biochem. J."},{"key":"ref_99","first-page":"507","article-title":"Ornithine decarboxylase inhibition and the malaria-infected red cell: A model for polyamine metabolism and growth","volume":"233","author":"Whaun","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00531084","article-title":"Cytostatic effect of DL-alpha-difluoromethylornithine against Plasmodium falciparum and its reversal by diamines and spermidine","volume":"73","author":"Assaraf","year":"1987","journal-title":"Parasitol. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/0006-2952(91)90174-4","article-title":"Irreversible inhibition of S-adenosylmethionine decarboxylase in Plasmodium falciparum-infected erythrocytes: Growth inhibition in vitro","volume":"41","author":"Wright","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/1043-6618(95)80017-4","article-title":"Combined action of inhibitors of polyamine biosynthetic pathway with a known antimalarial drug chloroquine on Plasmodium falciparum","volume":"31","author":"Das","year":"1995","journal-title":"Pharmacol. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1128\/AAC.34.7.1381","article-title":"Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis","volume":"34","author":"Bell","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1021\/jm030545e","article-title":"Parallel solution-phase synthesis of conformationally restricted congeners of pentamidine and evaluation of their antiplasmodial activities","volume":"47","author":"Mayence","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1211\/jpp.58.8.0003","article-title":"Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners","volume":"58","author":"Huang","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1021\/jm0708634","article-title":"Synthesis and in vitro antiprotozoal activity of bisbenzofuran cations","volume":"50","author":"Bakunova","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/j.ejmech.2009.03.014","article-title":"Synthesis and antiprotozoal activities of dicationic bis(phenoxymethyl)benzenes, bis(phenoxymethyl)naphthalenes, and bis(benzyloxy)naphthalenes","volume":"44","author":"Patrick","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1016\/j.bmc.2009.07.080","article-title":"Synthesis and activity of azaterphenyl diamidines against Trypanosoma brucei rhodesiense and Plasmodium falciparum","volume":"17","author":"Hu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.bmc.2010.03.058","article-title":"Synthesis and antiprotozoal activity of 2,5-bis[amidinoaryl]thiazoles","volume":"18","author":"Branowska","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bmc.2010.11.047","article-title":"Dicationic phenyl-2,2\u2019-bichalcophenes and analogues as antiprotozoal agents","volume":"19","author":"Ismail","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1016\/j.ejmech.2011.09.047","article-title":"Molecular modeling study and synthesis of novel dicationic flexible triaryl guanidines and imidamides as antiprotozoal agents","volume":"46","author":"Arafa","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1124\/mol.59.5.1298","article-title":"Diamidine compounds: Selective uptake and targeting in Plasmodium falciparum","volume":"59","author":"Stead","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.bmcl.2011.02.100","article-title":"Synthesis of benzologues of Nitazoxanide and Tizoxanide: A comparative study of their in vitro broad-spectrum antiprotozoal activity","volume":"21","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Vera, I.M., Grilo Ruivo, M.T., Lemos Rocha, L.F., Marques, S., Bhatia, S.N., Mota, M.M., and Mancio-Silva, L. (2019). Targeting liver stage malaria with metformin. JCI Insight., 4.","DOI":"10.1172\/jci.insight.127441"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.3389\/fimmu.2018.02942","article-title":"Metformin Promotes the Protection of Mice Infected with Plasmodium yoelii Independently of gammadelta T Cell Expansion","volume":"9","author":"Miyakoda","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0001-706X(97)00138-1","article-title":"Causal prophylactic activity of antihistaminic agents against Plasmodium yoelii nigeriensis infection in Swiss mice","volume":"69","author":"Singh","year":"1998","journal-title":"Acta Trop."},{"key":"ref_117","first-page":"130","article-title":"[Observation on the inhibitory effect of ketotifen, cyproheptadine and pizotifenum on Plasmodium falciparum in vitro]","volume":"6","author":"Zhou","year":"1988","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/00034983.1990.11812509","article-title":"The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents","volume":"84","author":"Peters","year":"1990","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0001-706X(00)00133-9","article-title":"Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis","volume":"77","author":"Singh","year":"2000","journal-title":"Acta Trop."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-2952(02)01299-6","article-title":"Haem polymerase as a novel target of antimalarial action of cyproheptadine","volume":"64","author":"Agrawal","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1073\/pnas.1118370109","article-title":"Liver-stage malaria parasites vulnerable to diverse chemical scaffolds","volume":"109","author":"Derbyshire","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1073\/pnas.1913525117","article-title":"Plasmodium chaperonin TRiC\/CCT identified as a target of the antihistamine clemastine using parallel chemoproteomic strategy","volume":"117","author":"Lu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nchembio806","article-title":"A clinical drug library screen identifies astemizole as an antimalarial agent","volume":"2","author":"Chong","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/AAC.32.4.462","article-title":"Stage-selective inhibition of rodent malaria by cyclosporine","volume":"32","author":"Murphy","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1128\/iai.37.3.1093-1100.1982","article-title":"Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro","volume":"37","author":"Nickell","year":"1982","journal-title":"Infect. Immun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/BF01978803","article-title":"Antimalarial activity of cyclosporin A","volume":"11","year":"1981","journal-title":"Agents Actions"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2008.09.005","article-title":"Effect of cyclosporine on parasitemia and survival of Plasmodium berghei infected mice","volume":"376","author":"Bobbala","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/expr.1996.0132","article-title":"Plasmodium vivax: In vitro antiparasitic effect of cyclosporins","volume":"84","author":"Kocken","year":"1996","journal-title":"Exp. Parasitol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1021\/la902580w","article-title":"The potent antimalarial drug cyclosporin A preferentially destabilizes sphingomyelin-rich membranes","volume":"26","author":"Azouzi","year":"2010","journal-title":"Langmuir"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1021\/la201040c","article-title":"The potent antimalarial peptide cyclosporin A induces the aggregation and permeabilization of sphingomyelin-rich membranes","volume":"27","author":"Azouzi","year":"2011","journal-title":"Langmuir"},{"key":"ref_131","unstructured":"World Health Organization (2016). Consolidated Guidelines on the Use of Antireviral Drugs for Treating and Preventing HIV Infection, WHO."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3389\/fmicb.2019.03048","article-title":"The Impact of Antiretroviral Therapy on Malaria Parasite Transmission","volume":"10","author":"Azevedo","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1074\/jbc.M409740200","article-title":"The role of Plasmodium falciparum food vacuole plasmepsins","volume":"280","author":"Liu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.actatropica.2005.11.001","article-title":"The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi","volume":"97","author":"Martins","year":"2006","journal-title":"Acta Trop."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Onchieku, N.M., Mogire, R., Ndung\u2019u, L., Mwitari, P., Kimani, F., Matoke-Muhia, D., Kiboi, D., and Magoma, G. (2018). Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201556"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/428781","article-title":"Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors","volume":"191","author":"Savarino","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/QAD.0000000000001266","article-title":"Buy one, get one free? Benefits of certain antiretrovirals against malaria","volume":"31","author":"Hobbs","year":"2017","journal-title":"AIDS"},{"key":"ref_138","unstructured":"Centers for Disease Control and Prevention (1985). Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. MMWR Morb. Mortal. Wkly. Rep., 34, 185\u2013195."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJM198508153130717","article-title":"Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum","volume":"313","author":"MacPherson","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","article-title":"Tetracyclines in malaria","volume":"14","author":"Gaillard","year":"2015","journal-title":"Malar. J."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(94)92526-7","article-title":"Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum","volume":"343","author":"Kuschner","year":"1994","journal-title":"Lancet"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-123-10-199511150-00005","article-title":"Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers","volume":"123","author":"Anderson","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1086\/516281","article-title":"Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya","volume":"26","author":"Andersen","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3201\/eid2006.131302","article-title":"Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania","volume":"20","author":"Schachterle","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/515071","article-title":"Malaria prophylaxis using azithromycin: A double-blind, placebo-controlled trial in Irian Jaya, Indonesia","volume":"28","author":"Taylor","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1475-2875-7-255","article-title":"Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy","volume":"7","author":"Chico","year":"2008","journal-title":"Malar. J."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2875-9-73","article-title":"Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication","volume":"9","author":"Shimizu","year":"2010","journal-title":"Malar. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4269\/ajtmh.16-0332","article-title":"Azithromycin for Malaria?","volume":"95","author":"Rosenthal","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/bmj.286.6373.1244","article-title":"Agranulocytosis associated with malaria prophylaxis with Maloprim","volume":"286","author":"Friman","year":"1983","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14787210.2.1.119","article-title":"Malaria chemoprophylaxis: When should we use it and what are the options?","volume":"2","author":"Petersen","year":"2004","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(10)60396-0","article-title":"The rise and fall of the antimalarial Lapdap: A lesson in pharmacogenetics","volume":"376","author":"Luzzatto","year":"2010","journal-title":"Lancet"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Manyando, C., Njunju, E.M., D\u2019Alessandro, U., and Van Geertruyden, J.P. (2013). Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: A systematic review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056916"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12936-016-1613-y","article-title":"Antibiotics in malaria therapy: Which antibiotics except tetracyclines and macrolides may be used against malaria?","volume":"15","author":"Gaillard","year":"2016","journal-title":"Malar. J."},{"key":"ref_154","unstructured":"World Health Organization (2015). Guidelines for the Treatment of Malaria, World Health Organization. [3rd ed.]."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0169-4758(93)90210-7","article-title":"Avermectins in arthropod vector management-prospects and pitfalls","volume":"9","author":"Wilson","year":"1993","journal-title":"Parasitol. Today"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1179\/136485908X337436","article-title":"The African Programme for Onchocerciasis Control (APOC)","volume":"102","author":"Amazigo","year":"2008","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Ottesen, E.A., Hooper, P.J., Bradley, M., and Biswas, G. (2008). The global programme to eliminate lymphatic filariasis: Health impact after 8 years. PLoS Negl. Trop. Dis., 2.","DOI":"10.1371\/journal.pntd.0000317"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(18)32321-3","article-title":"Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): A cluster-randomised trial","volume":"393","author":"Foy","year":"2019","journal-title":"Lancet"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/tmi.13357","article-title":"Ivermectin for causal malaria prophylaxis: A randomised controlled human infection trial","volume":"25","author":"Metzger","year":"2020","journal-title":"Trop. Med. Int. Health"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12936-017-2125-0","article-title":"Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi","volume":"16","author":"Kobylinski","year":"2017","journal-title":"Malar. J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1475-2875-11-381","article-title":"Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae","volume":"11","author":"Kobylinski","year":"2012","journal-title":"Malar. J."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Pinilla, Y.T., CPLopes, S., SSampaio, V., Andrade, F.S., Melo, G.C., Orfan\u00f3, A.S., Secundino, N.F., Guerra, M.G., Lacerda, M.V., and Kobylinski, K.C. (2018). Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006221"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s13071-019-3805-0","article-title":"Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins","volume":"12","author":"Azevedo","year":"2019","journal-title":"Parasit. Vectors"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/653208","article-title":"Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: The potential of oral insecticides in malaria control","volume":"202","author":"Chaccour","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0035-9203(00)90211-6","article-title":"The potential of ivermectin to control the malaria vector Anopheles farauti","volume":"94","author":"Foley","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1603\/ME11098","article-title":"Lethal and sublethal effects of avermectin\/milbemycin parasiticides on the African malaria vector, Anopheles arabiensis","volume":"49","author":"Fritz","year":"2012","journal-title":"J. Med. Entomol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actatropica.2010.06.001","article-title":"The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors","volume":"116","author":"Kobylinski","year":"2010","journal-title":"Acta Trop."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12936-017-1923-8","article-title":"Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles","volume":"16","author":"Kobylinski","year":"2017","journal-title":"Malar. J."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cid\/ciu797","article-title":"Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: A double-blind, randomized, clinical trial","volume":"60","author":"Ouedraogo","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1475-2875-9-365","article-title":"Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors","volume":"9","author":"Sylla","year":"2010","journal-title":"Malar. J."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/1475-2875-13-417","article-title":"Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments","volume":"13","author":"Alout","year":"2014","journal-title":"Malar. J."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.14-0187","article-title":"Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control","volume":"91","author":"Kobylinski","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.2011.11-0160","article-title":"Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages","volume":"85","author":"Kobylinski","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1475-2875-12-153","article-title":"Ivermectin to reduce malaria transmission: A research agenda for a promising new tool for elimination","volume":"12","author":"Chaccour","year":"2013","journal-title":"Malar. J."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12936-015-0691-6","article-title":"Establishment of the Ivermectin Research for Malaria Elimination Network: Updating the research agenda","volume":"14","author":"Chaccour","year":"2015","journal-title":"Malar. J."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pt.2011.05.007","article-title":"Endectocides for malaria control","volume":"27","author":"Foy","year":"2011","journal-title":"Trends Parasitol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/cid\/ciu802","article-title":"Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission?","volume":"60","author":"Steketee","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_178","unstructured":"World Health Organization (2020, June 15). Trypanosomiasis, Human African (Sleeping Sickness). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness)."},{"key":"ref_179","unstructured":"World Health Organization (2019). WHO Interim Guidelines for the Treatment of Gambiense Human African Trypanosomiasis, World Health Organization. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/ja00476a050","article-title":"Catalytic irreversible inhibition of mammalian ornithine decarboxylase by substrate and product analogues","volume":"100","author":"Metcalf","year":"1978","journal-title":"J. Am. Chem. Soc."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0014-4894(83)90062-0","article-title":"Plasmodium berghei: Inhibition of the sporogonous cycle by alpha-difluoromethylornithine","volume":"56","author":"Gillet","year":"1983","journal-title":"Exp. Parasitol."},{"key":"ref_182","first-page":"257","article-title":"Ketotifen in treatment of uncomplicated falciparum malaria","volume":"21","author":"Ibrahim","year":"2000","journal-title":"Saudi Med. J."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1179\/000349803235001516","article-title":"A randomized comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children","volume":"97","author":"Sowunmi","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1475-2875-12-173","article-title":"Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse","volume":"12","author":"Macareo","year":"2013","journal-title":"Malar. J."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s42003-019-0737-3","article-title":"A dual fluorescent Plasmodium cynomolgi reporter line reveals in vitro malaria hypnozoite reactivation","volume":"3","author":"Zeeman","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1021\/acs.analchem.0c00547","article-title":"Dual-Luciferase-Based Fast and Sensitive Detection of Malaria Hypnozoites for the Discovery of Antirelapse Compounds","volume":"92","author":"Zeeman","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","article-title":"Tuberculosis","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet"},{"key":"ref_188","unstructured":"World Health Organization, and Stop TB Initiative (World Health Organization) (2010). Treatment of Tuberculosis: Guidelines, World Health Organization. [4th ed.]."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00436-010-1789-y","article-title":"Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy","volume":"106","author":"Aditya","year":"2010","journal-title":"Parasitol. Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000007167","article-title":"Treatment of malaria tropica with a fixed combination of rifampicin, co-trimoxazole and isoniazid: A clinical study","volume":"45","author":"Goerg","year":"1999","journal-title":"Chemotherapy"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000239372","article-title":"Malaria therapy and prophylaxis with cotrifazid, a multiple complex combination consisting of rifampicin + isoniazid + sulfamethoxazole + trimethoprim","volume":"41","author":"Freerksen","year":"1995","journal-title":"Chemotherapy"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000239472","article-title":"Cotrifazid--an agent against malaria","volume":"42","author":"Freerksen","year":"1996","journal-title":"Chemotherapy"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Genton, B., Mueller, I., Betuela, I., Casey, G., Ginny, M., Alpers, M.P., and Reeder, J.C. (2006). Rifampicin\/Cotrimoxazole\/Isoniazid versus mefloquine or quinine + sulfadoxine- pyrimethamine for malaria: A randomized trial. PLoS Clin. Trials, 1.","DOI":"10.1371\/journal.pctr.0010038"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2004.01.002","article-title":"Isonicotinic acid hydrazide: An anti-tuberculosis drug inhibits malarial transmission in the mosquito gut","volume":"106","author":"Arai","year":"2004","journal-title":"Exp. Parasitol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/227381b0","article-title":"Inhibition of rodent malaria in mice by rifampicin","volume":"227","author":"Alger","year":"1970","journal-title":"Nature"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0035-9203(93)90497-E","article-title":"Antimalarial activity of rifampicin in vitro and in rodent models","volume":"87","author":"Strath","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/AAC.38.3.511","article-title":"Antimalarial effects of rifampin in Plasmodium vivax malaria","volume":"38","author":"Pukrittayakamee","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4269\/ajtmh.1989.40.240","article-title":"Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture","volume":"40","author":"Geary","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4269\/ajtmh.1983.32.221","article-title":"Effects of antibiotics on Plasmodium falciparum in vitro","volume":"32","author":"Geary","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0024-3205(87)90581-9","article-title":"Gentamicin and amikacin repress the growth of Plasmodium falciparum in culture, probably by inhibiting a parasite acid phospholipase","volume":"40","author":"Krugliak","year":"1987","journal-title":"Life Sci."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/00034983.1984.11811831","article-title":"Evaluation of a range of antimicrobial agents against the parasitic protozoa, Plasmodium falciparum, Babesia rodhaini and Theileria parva in vitro","volume":"78","author":"McColm","year":"1984","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/AAC.27.1.21","article-title":"Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture","volume":"27","author":"Divo","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/AAC.02711-13","article-title":"Sulfur mobilization for Fe-S cluster assembly by the essential SUF pathway in the Plasmodium falciparum apicoplast and its inhibition","volume":"58","author":"Charan","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exppara.2019.01.015","article-title":"Functional analysis of iron-sulfur cluster biogenesis (SUF pathway) from Plasmodium vivax clinical isolates","volume":"198","author":"Pala","year":"2019","journal-title":"Exp. Parasitol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1017\/S0031182011000850","article-title":"Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice","volume":"138","author":"Tripathi","year":"2011","journal-title":"Parasitology"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lfs.2015.06.027","article-title":"Clarithromycin enhances the antimalarial efficacy of mefloquine via its increased bioavailability and disrupting P. falciparum apicoplast","volume":"136","author":"Gunjan","year":"2015","journal-title":"Life Sci."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Uddin, T., McFadden, G.I., and Goodman, C.D. (2018). Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.01161-17"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bmc.2014.11.028","article-title":"Clofazimine analogs with antileishmanial and antiplasmodial activity","volume":"23","author":"Barteselli","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4314\/ahs.v17i1.24","article-title":"In vitro investigation of clofazimine analogues for antiplasmodial, cytotoxic and pro-oxidative activities","volume":"17","author":"Makgatho","year":"2017","journal-title":"Afr. Health Sci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/AAC.00892-07","article-title":"Telithromycin and quinupristin-dalfopristin induce delayed death in Plasmodium falciparum","volume":"52","author":"Barthel","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1747-0285.2006.00391.x","article-title":"Searching for new antimalarial therapeutics amongst known drugs","volume":"67","author":"Weisman","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI34261","article-title":"Helminth infections: The great neglected tropical diseases","volume":"118","author":"Hotez","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_213","unstructured":"World Health Organization (2020, May 22). Soil-Transmitted Helminth Infections. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/soil-transmitted-helminth-infections."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0309-1651(89)90135-5","article-title":"Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro","volume":"13","author":"Franklin","year":"1989","journal-title":"Cell Biol. Int. Rep."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0035-9203(97)90035-3","article-title":"The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro","volume":"91","author":"Davis","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/expr.1998.4238","article-title":"Plasmodium berghei: In vivo efficacy of albendazole in different rodent models","volume":"88","author":"Dow","year":"1998","journal-title":"Exp. Parasitol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/expr.2000.4491","article-title":"Plasmodium berghei: The antimalarial activity of albendazole in rats is mediated via effects on the hematopoietic system","volume":"94","author":"Dow","year":"2000","journal-title":"Exp. Parasitol."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Hurlimann, E., Houngbedji, C.A., N\u2019Dri, P.B., Banninger, D., Coulibaly, J.T., Yap, P., Silue, K.D., N\u2019Goran, E.K., Raso, G., and Utzinger, J. (2014). Effect of deworming on school-aged children\u2019s physical fitness, cognition and clinical parameters in a malaria-helminth co-endemic area of Cote d\u2019Ivoire. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-411"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/infdis\/jiv382","article-title":"Effect of Repeated Anthelminthic Treatment on Malaria in School Children in Kenya: A Randomized, Open-Label, Equivalence Trial","volume":"213","author":"Kepha","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Kirwan, P., Jackson, A.L., Asaolu, S.O., Molloy, S.F., Abiona, T.C., Bruce, M.C., Ranford-Cartwright, L., SM, O.N., and Holland, C.V. (2010). Impact of repeated four-monthly anthelmintic treatment on Plasmodium infection in preschool children: A double-blind placebo-controlled randomized trial. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-277"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Midzi, N., Mtapuri-Zinyowera, S., Sangweme, D., Paul, N.H., Makware, G., Mapingure, M.P., Brouwer, K.C., Mudzori, J., Hlerema, G., and Chadukura, V. (2011). Efficacy of integrated school based de-worming and prompt malaria treatment on helminths -Plasmodium falciparum co-infections: A 33 months follow up study. BMC Int. Health Hum. Rights, 11.","DOI":"10.1186\/1472-698X-11-9"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Wiria, A.E., Prasetyani, M.A., Hamid, F., Wammes, L.J., Lell, B., Ariawan, I., Uh, H.W., Wibowo, H., Djuardi, Y., and Wahyuni, S. (2010). Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-77"},{"key":"ref_223","unstructured":"World Health Organization (2020, May 22). Lymphatic Filariasis. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lymphatic-filariasis."},{"key":"ref_224","unstructured":"World Health Organization (2020, May 22). Onchocerciasis. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/onchocerciasis."},{"key":"ref_225","unstructured":"World Health Organization (2020, May 22). Schistosomiasis. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis."},{"key":"ref_226","unstructured":"World Health Organization (2020, May 22). Fascioliasis Diagnosis, Treatment and Control Strategy. Available online: https:\/\/www.who.int\/foodborne_trematode_infections\/fascioliasis\/fascioliasis_diagnosis\/en\/."},{"key":"ref_227","unstructured":"World Health Organization (2010, January 22\u201326). Control of the Leishmaniases. Proceedings of the Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, Switzerland."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00034983.1989.11812354","article-title":"The effect of pentostam and cimetidine on the development of leishmaniasis (Leishmania mexicana amazonensis) and concomitant malaria (Plasmodium yoelii)","volume":"83","author":"Coleman","year":"1989","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/AAC.49.2.493-496.2005","article-title":"Potent plasmodicidal activity of a heat-induced reformulation of deoxycholate-amphotericin B (Fungizone) against Plasmodium falciparum","volume":"49","author":"Hatabu","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.bcp.2005.12.012","article-title":"Selective lysis of erythrocytes infected with the trophozoite stage of Plasmodium falciparum by polyene macrolide antibiotics","volume":"71","author":"Wiehart","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1073\/pnas.0307742101","article-title":"A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation","volume":"101","author":"Pessi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbapap.2009.10.009","article-title":"Malaria: Targeting Parasite and Host Cell Kinomes","volume":"1804","author":"Doerig","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/jm201095h","article-title":"Targeting the Liver Stage of Malaria Parasites: A Yet Unmet Goal","volume":"55","author":"Rodrigues","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pt.2011.09.004","article-title":"A Toolbox to Study Liver Stage Malaria","volume":"27","author":"Mota","year":"2011","journal-title":"Trends Parasitol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acsinfecdis.9b00144","article-title":"Flexible 3D Cell-Based Platforms for the Discovery and Profiling of Novel Drugs Targeting Plasmodium Hepatic Infection","volume":"5","author":"Arez","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/acs.jmedchem.0c00033","article-title":"Molecular Design and Synthesis of Ivermectin Hybrids Targeting Hepatic and Erythrocytic Stages of Plasmodium Parasites","volume":"63","author":"Singh","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_237","unstructured":"World Health Organization (2020, June 26). WHO Model Lists of Essential Medicines. Available online: https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"e1375","DOI":"10.1016\/S2214-109X(19)30374-2","article-title":"Burden of Non-Communicable Diseases in sub-Saharan Africa, 1990\u20132017: Results from the Global Burden of Disease Study 2017","volume":"7","author":"Gouda","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/138161213804070276","article-title":"Targeting host factors to circumvent anti-malarial drug resistance","volume":"19","author":"Mota","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-0196-3","article-title":"Malaria Vaccines since 2000: Progress, Priorities, Products","volume":"5","author":"Duffy","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile Protection against Human Malaria by Chemoattenuated PfSPZ Vaccine","volume":"542","author":"Surat","year":"2017","journal-title":"Nature"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1073\/pnas.1615324114","article-title":"Attenuated PfSPZ Vaccine Induces Strain-Transcending T Cells and Durable Protection against Heterologous Controlled Human Malaria Infection","volume":"114","author":"Lyke","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"eaay2578","DOI":"10.1126\/scitranslmed.aay2578","article-title":"An Open-Label Phase 1\/2a Trial of a Genetically Modified Rodent Malaria Parasite for Immunization against Plasmodium falciparum Malaria","volume":"12","author":"Reuling","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40265-018-0911-9","article-title":"Drugs in Development for Malaria","volume":"78","author":"Ashley","year":"2018","journal-title":"Drugs"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1172\/JCI82981","article-title":"Current therapies and future possibilities for drug development against liver-stage malaria","volume":"126","author":"Raphemot","year":"2016","journal-title":"J. Clin. Investig."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/15\/3409\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:52:13Z","timestamp":1760176333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/15\/3409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":246,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["molecules25153409"],"URL":"https:\/\/doi.org\/10.3390\/molecules25153409","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]}}}